Advertisement

U.S. markets closed

S&P 500
4,228.48
-55.26(-1.29%)
Dow 30
33,706.74
-292.30(-0.86%)
Nasdaq
12,705.21
-260.13(-2.01%)
Russell 2000
1,957.35
-43.38(-2.17%)
Crude Oil
89.91
-0.59(-0.65%)
Gold
1,760.30
-10.90(-0.62%)

Advertisement

Natera, Inc. (NTRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

50.37

-1.66

(-3.19%)

At close: 04:00PM EDT

50.37

0.00

(0.00%)

After hours:

04:06PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Short-term KST

View all chart patterns

Performance Outlook

Previous Close	52.03
Open	51.20
Bid	48.28 x 1100
Ask	51.90 x 900
Day's Range	49.19 - 51.61
52 Week Range	26.10 - 129.09
Volume	954,728
Avg. Volume	1,323,517

Market Cap	4.884B
Beta (5Y Monthly)	1.33
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NTRA

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Natera, Inc.
Analyst Report: Quest Diagnostics, Inc.Quest Diagnostics is a provider of clinical diagnostic services that help to identify and treat disease and improve healthcare management. The company incorporated in Delaware in 1990; its predecessor companies date back to 1967. Quest is based in Secaucus, New Jersey and employs roughly 49,000 people; the stock is a component of the S&P 500.
Rating
Fair Value
Economic Moat
2 days agoArgus Research

News

Zacks
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -2.04% and 2.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Wall Street Analysts Predict a 47% Upside in Natera (NTRA): Here's What You Should Know
The consensus price target hints at a 47.5% upside potential for Natera (NTRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Earnings Preview: DermTech, Inc. (DMTK) Q2 Earnings Expected to Decline
DermTech, Inc. (DMTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Advertisement

S&P 5004,228.48-55.26(-1.29%)

Dow 3033,706.74-292.30(-0.86%)

Nasdaq12,705.21-260.13(-2.01%)

Russell 20001,957.35-43.38(-2.17%)

Crude Oil89.91-0.59(-0.65%)

Gold1,760.30-10.90(-0.62%)

Natera, Inc. (NTRA)

Chart Events

Performance Outlook

Fair Value

Related Research

Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

Wall Street Analysts Predict a 47% Upside in Natera (NTRA): Here's What You Should Know

Earnings Preview: DermTech, Inc. (DMTK) Q2 Earnings Expected to Decline

S&P 500
4,228.48
-55.26(-1.29%)

Dow 30
33,706.74
-292.30(-0.86%)

Nasdaq
12,705.21
-260.13(-2.01%)

Russell 2000
1,957.35
-43.38(-2.17%)

Crude Oil
89.91
-0.59(-0.65%)

Gold
1,760.30
-10.90(-0.62%)